Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,128Revenue $M97.9Net Margin (%)-60.1Altman Z-Score20.2
Enterprise Value $M6,970EPS $-0.6Operating Margin %-142.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score4.2Pre-tax Margin (%)-64.0Higher ROA y-yN
Price/Book11.010-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales67.65-y EBITDA Growth Rate %--Current Ratio4.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-9.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-13.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M109ROIC % (ttm)-49.1Gross Margin Increase y-yN

Gurus Latest Trades with XON

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XONFirst Eagle Investment 2015-03-31 Add$26.08 - $50.16
($37.59)
$ 65.2574%Add 4.84%828,104
XONT Boone Pickens 2014-12-31 Buy 0.53%$16.61 - $28.02
($23.05)
$ 65.25183%New holding10,000
XONDavid Einhorn 2014-12-31 Sold Out -0.05%$16.61 - $28.02
($22.97)
$ 65.25184%Sold Out0
XONDavid Einhorn 2014-09-30 Reduce-0.06%$17.86 - $26.59
($21.29)
$ 65.25206%Reduce 47.39%197,278
XONDavid Einhorn 2014-06-30 Reduce-0.39%$15.3 - $25.93
($21.15)
$ 65.25209%Reduce 72.81%375,000
XONFirst Eagle Investment 2014-06-30 Buy 0.04%$15.3 - $25.93
($21.15)
$ 65.25209%New holding661,564
XONDavid Einhorn 2014-03-31 Reduce-0.26%$22.5 - $36.82
($28.82)
$ 65.25126%Reduce 37.58%1,379,014
XONT Boone Pickens 2013-12-31 Sold Out -0.47%$17.65 - $25.5
($21.05)
$ 65.25210%Sold Out0
XONDavid Einhorn 2013-09-30 Buy 0.86%$21.36 - $29.7
($24.16)
$ 65.25170%New holding2,176,868
XONT Boone Pickens 2013-09-30 Buy 0.47%$21.36 - $29.7
($24.16)
$ 65.25170%New holding12,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XON is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XON: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JCEO, 10% Owner 2015-01-27Buy555,556$27141.67view
KIRK RANDAL JCEO, 10% Owner 2014-05-13Buy65,173$15.19329.56view
Lehr Donald P.Chief Legal Officer 2014-05-13Buy1,850$15.99308.07view
Reed Thomas D.Chief Science Officer 2014-05-13Buy640$15.6318.27view
Krishnan SumaSVP--Product Development 2014-05-09Buy20,900$14.21359.18view
Krishnan Krish SCOO 2014-05-09Buy20,900$14.21359.18view
Kasser Thomas R.SVP--Food Sector 2014-05-09Buy10,000$13.39387.3view
Huang KellySVP-Consumer Sector 2014-05-09Buy3,200$15.78313.5view
KIRK RANDAL JCEO, 10% Owner 2014-05-09Buy67,333$15.16330.41view
KIRK RANDAL JCEO, 10% Owner 2014-03-27Buy243,001$25.72153.69view

Quarterly/Annual Reports about XON:

News about XON:

Articles On GuruFocus.com
Intrexon Corp is expanding his business Jun 25 2015 
Bill Miller Identifies What Could Be The Stock of The Decade Feb 10 2015 
5-Year Lows: American Eagle Outfitters, Intrexon Corp, Mack-Cali Realty Corp, and Weight Watchers In Apr 20 2014 
Daniel Loeb Comments on Intrexon Corporation Jan 22 2014 
Daniel Loeb Lags S&P But Top New Stocks Advance Jan 07 2014 
David Einhorn’s New Stocks – TPX, XON, NVR Nov 14 2013 
Weekly CEO Buys Highlight: XON, ARCP, FSFR, CNTY, RHP Aug 18 2013 

More From Other Websites
McKesson (MCK) Tops Q1 Earnings, Ups Fiscal '16 Outlook - Analyst Blog Jul 30 2015
5 stocks to watch Jul 29 2015
Trending Now: XON Jul 28 2015
Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study Jul 28 2015
Wunderlich Hikes Intrexon To $70, Sees 'Software/Biotech Hybrid' As A Key Strength Jul 27 2015
ZIOPHARM Announces Orphan Drug Designation for Ad-RTS-hIL-12 in the Treatment of Malignant Glioma Jul 24 2015
INTREXON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jul 21 2015
Fibrocell Announces Proposed Public Offering of Common Stock Jul 21 2015
Intrexon Augments Management Team Jul 21 2015
Intrexon Augments Management Team Jul 21 2015
Fibrocell and Intrexon Announce IND Filing of FCX-007 for the Treatment of Recessive Dystrophic... Jul 20 2015
Fibrocell and Intrexon Announce IND Filing of FCX-007 for the Treatment of Recessive Dystrophic... Jul 20 2015
Intrexon to Present at Upcoming Industrial Biotechnology Conferences Jul 17 2015
Intrexon to Present at Upcoming Industrial Biotechnology Conferences Jul 17 2015
Can the Uptrend Continue for Intrexon (XON)? - Tale of the Tape Jul 16 2015
Biotech Leader Celgene Breaks Out From Base Jul 15 2015
Stock Market Today - 07/15/15 Jul 15 2015
4 Big-Volume Stocks to Trade for Breakouts Jul 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK